Literature DB >> 20818898

Nonadherence to imatinib during an economic downturn.

Robin K Kelley, Alan P Venook.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20818898     DOI: 10.1056/NEJMc1004656

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  What's fueling the biotech engine-2009-2010.

Authors:  Saurabh Aggarwal
Journal:  Nat Biotechnol       Date:  2010-11       Impact factor: 54.908

Review 2.  How will B-cell-receptor-targeted therapies change future CLL therapy?

Authors:  Jeffrey A Jones; John C Byrd
Journal:  Blood       Date:  2014-01-06       Impact factor: 22.113

3.  Rural Disparities in Treatment-Related Financial Hardship and Adherence to Surveillance Colonoscopy in Diverse Colorectal Cancer Survivors.

Authors:  Jean A McDougall; Matthew P Banegas; Charles L Wiggins; Vi K Chiu; Ashwani Rajput; Anita Y Kinney
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-03-28       Impact factor: 4.254

4.  The Economic Burden of Out-of-Pocket Expenses for Plastic Surgery Procedures.

Authors:  Jessica I Billig; Jung-Sheng Chen; Yu-Ting Lu; Kevin C Chung; Erika D Sears
Journal:  Plast Reconstr Surg       Date:  2020-06       Impact factor: 4.730

5.  Racial Disparity in Incidence and Survival for Gastrointestinal Stromal Tumors (GISTs): an Analysis of SEER Database.

Authors:  Mark B Ulanja; Mohit Rishi; Bryce D Beutler; Kenneth G Konam; Santhosh Ambika; Tomas Hinojosa; Francis T Djankpa; Wei Yang; Nageshwara Gullapalli
Journal:  J Racial Ethn Health Disparities       Date:  2019-06-18

6.  A composite measure of personal financial burden among patients with stage III colorectal cancer.

Authors:  Christine M Veenstra; Scott E Regenbogen; Sarah T Hawley; Jennifer J Griggs; Mousumi Banerjee; Ikuko Kato; Kevin C Ward; Arden M Morris
Journal:  Med Care       Date:  2014-11       Impact factor: 2.983

7.  Proposal for a novel methodology to screen and score cost versus survival for anticancer drugs in metastatic disease: could cost weigh in evaluation?

Authors:  Helmy M Guirgis
Journal:  J Oncol Pract       Date:  2012-07       Impact factor: 3.840

8.  Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey.

Authors:  Yuko Kodama; Ryoko Morozumi; Tomoko Matsumura; Yukiko Kishi; Naoko Murashige; Yuji Tanaka; Morihito Takita; Nobuyo Hatanaka; Eiji Kusumi; Masahiro Kami; Akihiko Matsui
Journal:  BMC Cancer       Date:  2012-04-24       Impact factor: 4.430

9.  The Increasing Financial Burden of Outpatient Elective Surgery for the Privately Insured.

Authors:  Jessica I Billig; Wen-Ching Lan; Kevin C Chung; Chang-Fu Kuo; Erika D Sears
Journal:  Ann Surg       Date:  2020-09-01       Impact factor: 13.787

Review 10.  Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia.

Authors:  Maria Helena de Almeida; Laura Fogliatto; Dulce Couto
Journal:  Rev Bras Hematol Hemoter       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.